Table 1

Patient characteristics

No. of patients
No. of patients24
Gender: male/female13/11
Age (yr)
 Median60
 Range29–80
Eastern Cooperative Oncology Group
 0 5
 116
 2 3
Previous therapy
 Chemotherapy24
 Median (range)3 (1–8)
 ≥4 prior regimens 9
 Radiotherapy13
 Immunotherapy 3
Treatment on study
 Median no. of cycles of DHA-paclitaxel 2
 Mean no. of cycles of DHA-paclitaxel3.3
 Range1–8
Tumor type
 Colorectal 8
 Breast 3
 Prostate 3
 Prostate 2
 Sarcoma 2
 Esophageal 2
 Other (ovary, anal, hepatoma, and non- small cell lung cancer)1 each